Picture of Canopy Growth logo

CGC Canopy Growth Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapValue Trap

Annual income statement for Canopy Growth, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.

2021
March 31st
R2022
March 31st
R2023
March 31st
2024
March 31st
2025
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue547510333297269
Cost of Revenue
Gross Profit67-79.518.379.981.5
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses1,7891,6102,963538364
Operating Profit-1,243-1,100-2,630-241-94.8
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-1,684-340-3,086-471-597
Provision for Income Taxes
Net Income After Taxes-1,671-331-3,080-484-604
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-1,745-310-3,278-657-598
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-1,745-310-3,278-657-598
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-35.3-0.211-33.9-5.47-5.36